Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Revenue (2016 - 2025)

CV Sciences (CVSI) has disclosed Revenue for 13 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 14.86% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Dec 2025, down 12.2% year-over-year, with the annual reading at $13.8 million for FY2025, 12.2% down from the prior year.
  • Revenue hit $3.3 million in Q4 2025 for CV Sciences, up from $3.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.1 million in Q2 2021 to a low of $3.3 million in Q3 2025.
  • Historically, Revenue has averaged $4.1 million across 5 years, with a median of $4.0 million in 2023.
  • Biggest five-year swings in Revenue: plummeted 41.43% in 2021 and later grew 9.01% in 2023.
  • Year by year, Revenue stood at $5.0 million in 2021, then dropped by 22.14% to $3.9 million in 2022, then fell by 1.76% to $3.8 million in 2023, then rose by 2.18% to $3.9 million in 2024, then fell by 14.86% to $3.3 million in 2025.
  • Business Quant data shows Revenue for CVSI at $3.3 million in Q4 2025, $3.3 million in Q3 2025, and $3.6 million in Q2 2025.